AMPLY Discovery Raises $1.75M to Revolutionize Drug Discovery with AI
AMPLY Discovery, a biotech startup focused on AI driven drug discovery, has successfully raised $1.75 million in seed funding, led by Twin Path Ventures.
The capital will support the company’s efforts to develop innovative treatments targeting aggressive cancers and drug-resistant infections.
AI Driven AMPLY Discovery Lands $1.75M to Accelerate Precision Medicine
Founded in 2021, AMPLY Discovery utilizes artificial intelligence, gene sequencing, and synthetic biology to create personalized therapies for diseases caused by genetic variations.
The company’s platform aims to expedite the development of treatments for conditions such as triple-negative breast cancer and acute myeloid leukemia.
With this latest round of funding, AMPLY Discovery is poised to continue its growth in the precision medicine space, advancing the future of personalized healthcare.
Kaynak: https://www.finsmes.com/2025/05/amply-discovery-closes-1-75m-seed-funding.html
